Atlanta Braves Holdings, Inc SEC Filings

Jill L. Robinson, EVP, CFO & Treasurer of Atlanta Braves Holdings, Inc. (BATRK), reported transactions dated 08/15/2025. She exercised a stock option to acquire 40,000 Series C shares at an exercise price of $27.18, which increased her reported beneficial ownership to 108,755 shares. On the same date she sold 40,000 Series C shares under a Rule 10b5-1 sales plan adopted May 15, 2025, at a weighted average sale price of $43.82 (range $43.68 to $44.12), leaving 68,755 Series C shares beneficially owned after the sale. The Form 4 was signed by an attorney-in-fact on 08/19/2025.

Atlanta Braves Holdings, Inc. (BATRK) reported a Rule 144 notice for the proposed sale of 40,000 shares of Series C common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $1,760,800.00. The filing shows the same 40,000 shares were acquired and paid for on 08/15/2025 by exercise of stock options and paid in cash, and no sales by the reporting person were reported in the prior three months.

The notice includes the standard representation that the seller does not possess undisclosed material adverse information. Outstanding shares are listed as 51,459,265, which provides context for the size of the transaction versus the company’s share base.

Atlanta Braves Holdings, Inc. (BATRK) – Form 4 insider transaction summary (filed 06/23/2025)

Executive Vice-President, Business Derek G. Schiller reported a paired exercise-and-sell program executed under a Rule 10b5-1 plan adopted on 09/06/2024. The transactions occurred on 06/18/2025 and 06/20/2025 and involved the company’s Series C common stock.

• Option exercises (Code “M”): 70,000 options were exercised at an exercise price of $27.18, split into 40,000 shares on 06/18 and 30,000 shares on 06/20.
• Open-market sales (Code “S”): All 70,000 newly issued shares were immediately sold at prices ranging from $44.00 – $46.00, generating gross proceeds of roughly $3.1 million and a spread of ~$17–19 per share over the strike price.
• Resulting positions: • Direct common-stock ownership remained unchanged at 300,233 shares. • Derivative (option) holdings declined to 175,395 options, down from 245,395 prior to the two exercises.

The filing indicates Schiller monetised a portion of his vested options while maintaining his common-stock stake, suggesting liquidity-driven activity rather than a reduction in his equity interest. Because the sales were conducted under a pre-arranged 10b5-1 plan, they carry less signalling weight than discretionary sales, yet investors may still view the sizeable dollar amount as a modestly negative sentiment indicator.

Atlanta Braves Holdings, Inc. (BATRK) – Form 4 insider activity

On 06/20/2025, entities affiliated with Mario J. Gabelli – including GAMCO Investors, Associated Capital Group, GGCP and several limited partnerships – filed a Form 4 reporting a sale of 100 Series A common shares at $48.12 through Limited Partnership III. The filing notes that disgorgement was paid to the issuer for this transaction.

Following the sale, the reporting group’s stated beneficial holdings comprise: 3,700 shares held indirectly by LP III; 27,152 shares owned directly by Mr. Gabelli; 12,000 shares by Associated Capital Group; 42,000 shares by GGCP; and an additional 50,300 shares held across four other limited partnerships (I, II, IV and V). The total reported amount equals approximately 135,152 Series A shares, though the group disclaims ownership in excess of its pecuniary interest.

No derivative securities were listed, and the group remains a 10 % owner. Given the very small size of the disposition relative to the overall stake, the transaction is viewed as routine portfolio management rather than a strategic signal. Market impact is expected to be negligible.

Atlanta Braves Holdings, Inc. (BATRK) – Form 144 filing discloses a proposed insider sale of the company’s Series C common stock.

Shares to be sold: 30,000. Aggregate market value: $1,365,000. Approximate sale date: 06/20/2025. Broker: UBS Financial Services Inc., 11 Madison Ave., New York, NY 10010. Exchange: NASDAQ. Total Series C shares outstanding: 51,297,110, making the proposed transaction roughly 0.06 % of the class.

The seller proposes to dispose of the shares that were acquired by exercising stock options on 06/20/2025; the consideration paid was cash. The filing also details prior sales within the last three months by Derek Schiller at the same address (755 Battery Avenue SE, Atlanta, GA 30339):

• 72,505 shares sold on 06/11/2025 for gross proceeds of $3,117,767.01
• 40,000 shares sold on 06/18/2025 for gross proceeds of $1,760,000.00

Cumulatively, 112,505 shares have already been sold in the past quarter for $4,877,767.01, representing roughly 0.22 % of the outstanding Series C shares. Including the newly-noticed 30,000 shares, total potential dispositions reach 142,505 shares (≈0.28 % of the class) with an aggregate value in excess of $6.2 million.

The signer affirms no knowledge of undisclosed material adverse information and, if applicable, compliance with Rule 10b5-1 trading plans. No remarks, plan-adoption date, or additional issuer details were supplied in the filing.

Atlanta Braves Holdings, Inc. (Ticker: BATRK) has filed a Form 144 indicating an intention to sell restricted securities under Rule 144.

The notice covers 40,000 shares of the company’s Series C common stock with an aggregate market value of $1.76 million, to be brokered through UBS Financial Services on or about 18 June 2025 on the NASDAQ market. Outstanding shares of the Series C class are reported at 51,297,110, making the proposed sale roughly 0.08 % of that class.

The filing also discloses that Derek Schiller—listed in the “Securities Sold During the Past 3 Months” table—sold 72,505 shares of the same class on 11 June 2025 for $3.12 million. Together with the new notice, insider sales over the last quarter total 112,505 shares valued at approximately $4.88 million, or about 0.22 % of the outstanding Series C float.

The shares to be sold were acquired via option exercise on 18 June 2025 and paid for in cash, as disclosed under “Nature of Acquisition Transaction.” The filer represents that no undisclosed material adverse information is known, in line with Rule 144 requirements.

Key Takeaways:

• Form 144 signals a potential insider sale but is not, by itself, a commitment to sell.
• The size of the planned sale is small relative to total shares outstanding, suggesting limited direct dilution or market impact.
• Investors may nonetheless monitor continued insider activity for sentiment signals, especially given the recent prior sale by the same insider.